Joost Wauters
Impact in
- Infectious Diseases top 1%
- Antifungal resistance and susceptibility
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Antifungal resistance and susceptibility 42
- Antimicrobial Resistance in Staphylococcus 9
- COVID-19 Clinical Research Studies 9
- Epidemiology 47
- Fungal Infections and Studies 26
- Pneumonia and Respiratory Infections 9
- Sepsis Diagnosis and Treatment 8
- Co-authors
- Isabel Spriet (40 shared papers)Alexander Wilmer (22 shared papers)Katrien Lagrou (24 shared papers)Philippe Meersseman (20 shared papers)Johan Maertens (13 shared papers)Greet Hermans (16 shared papers)Manu L. N. G. Malbrain (6 shared papers)Lore Vanderbeke (10 shared papers)
- Journals
- Critical Care (7 papers)Journal of Antimicrobial Chemotherapy (6 papers)Antibiotics (6 papers)Clinical Microbiology and Infection (4 papers)Mycoses (3 papers)
- Partner nations
- BelgiumNetherlandsUnited Kingdom
In The Last Decade
Joost Wauters
113 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 133
- Infectious Diseases 1.1k
- Applied Microbiology and Biotechnology 89
- Critical Care and Intensive Care Medicine 173
- Epidemiology 913
- Obstetrics and Gynecology 145
Countries citing papers authored by Joost Wauters
This map shows the geographic impact of Joost Wauters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joost Wauters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joost Wauters more than expected).
Fields of papers citing papers by Joost Wauters
This network shows the impact of papers produced by Joost Wauters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joost Wauters. The network helps show where Joost Wauters may publish in the future.
Co-authors
The 25 scholars most cited alongside Joost Wauters, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 197 | |
| 2 | 2003 | 176 | |
| 3 | 2019 | 160 | |
| 4 | 2021 | 134 | |
| 5 | 2018 | 121 | |
| 6 | 2014 | 108 | |
| 7 | 2011 | 76 | |
| 8 | 2011 | 70 | |
| 9 | 2020 | 58 | |
| 10 | 2021 | 54 | |
| 11 | 2009 | 51 | |
| 12 | 2017 | 50 | |
| 13 | 2021 | 48 | |
| 14 | 2014 | 48 | |
| 15 | 2010 | 43 | |
| 16 | 2012 | 41 | |
| 17 | 2021 | 39 | |
| 18 | 2020 | 39 | |
| 19 | 2009 | 38 | |
| 20 | 2015 | 37 |
About Joost Wauters
Joost Wauters is a scholar working on Infectious Diseases, Epidemiology, Pulmonary and Respiratory Medicine, Pharmacology and Surgery, having authored 117 papers that have together received 2.4k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (42 papers), Fungal Infections and Studies (26 papers), Antibiotics Pharmacokinetics and Efficacy (24 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Pneumonia and Respiratory Infections (9 papers), COVID-19 Clinical Research Studies (9 papers), Sepsis Diagnosis and Treatment (8 papers) and Antibiotic Resistance in Bacteria (7 papers). The work is most often cited by research in Infectious Diseases (1.1k citations), Applied Microbiology and Biotechnology (89 citations), Critical Care and Intensive Care Medicine (173 citations), Epidemiology (913 citations) and Obstetrics and Gynecology (145 citations). Joost Wauters has collaborated with scholars based in Belgium, Netherlands and United Kingdom. Frequent co-authors include Isabel Spriet, Alexander Wilmer, Katrien Lagrou, Philippe Meersseman, Johan Maertens, Greet Hermans, Manu L. N. G. Malbrain, Lore Vanderbeke, Paul E. Verweij and Roger J. M. Brüggemann. Their work appears in journals such as Critical Care, Journal of Antimicrobial Chemotherapy, Antibiotics, Clinical Microbiology and Infection and Mycoses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.